Revium Rx. (RVRC)

Name: Revium Rx. (RVRC) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001839140 · OTC · Pharmaceutical Preparations

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

Key ratios (year ended 2025-12-31)

-195.5%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31
Net Income	-$13.25M	-$13.45M	n/a
EPS (Diluted)	n/a	-$0.22	n/a
Total Assets	$7.11M	$8.30M	$20.28M
Total Liabilities	$1.59M	$1.42M	$576.0K
Shareholders' Equity	$5.52M	$6.88M	$19.71M
Cash & Equivalents	$842.0K	$1.68M	$3.27M
Shares Outstanding	60.73M	60.73M	60.73M
Weighted Average Diluted Shares	n/a	60.73M	n/a
EPS (Basic)	n/a	-$0.22	n/a